TP53 and central nervous system cancer: Across HGGs, TP53 (57%, 36/63) and H3F3A (54%, 34/63) were both most mutated and co-occurring genes (Figures 2A and 2C), followed by frequent mutations in ATRX (29%, 18/63), which is commonly mutated in gliomas.30